Aurisco Pharmaceutical Co, 0.3% 26jul2030, CNY (Conv.)
国内債券, 変動利付, 転換社債
国内債券, 変動利付, 転換社債
|
Aurisco Pharmaceutical Co., Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. ...
Aurisco Pharmaceutical Co., Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Tiantai, China.
|
| Step-up/Step-down |
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡